How has been the historical performance of Zim Laboratories?

Answer:The historical performance of Zim Laboratories shows a mixed trend in key financial metrics over the years.

Breakdown:
Zim Laboratories reported net sales of 379.03 Cr for the year ending March 2025, reflecting a slight increase from 367.42 Cr in March 2024 but a decrease from 398.53 Cr in March 2023. The total operating income for March 2025 was also 379.03 Cr, with total expenditure (excluding depreciation) at 335.31 Cr, leading to an operating profit (PBDIT) of 49.50 Cr. This was a rise from 46.51 Cr in March 2024 but a decline from 58.40 Cr in March 2023. The profit before tax decreased to 18.01 Cr in March 2025 from 23.64 Cr in March 2024 and 35.36 Cr in March 2023, while the profit after tax was reported at 12.17 Cr, down from 17.25 Cr in the previous year and 24.43 Cr in March 2023. The earnings per share (EPS) for March 2025 was 2.5, a decline from 3.54 in March 2024 and 5.01 in March 2023. On the balance sheet, total assets increased to 472.02 Cr in March 2025 from 446.82 Cr in March 2024, with total liabilities also rising to 472.02 Cr from 446.82 Cr. Cash flow from operating activities improved to 41.00 Cr in March 2025 from 16.00 Cr in March 2024, although the net cash outflow was recorded at -7.00 Cr for March 2025 compared to a net inflow of 3.00 Cr in March 2024. Overall, while Zim Laboratories has shown growth in certain areas, it faces challenges in profitability and cash flow management.